Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
European Journal of Medicinal Chemistry
|
March 14, 2015
Computer aided drug discovery of highly ligand efficient, low molecular weight imidazopyridine analogs as FLT3 inhibitors
Brendan Frett, Nick McConnell, Catherine C Smith, et al.
Molecular Diversity
|
January 18, 2018
Recent advances in the development of polycyclic skeletons via Ugi reaction cascades
Jie Lei, Jiang-Ping Meng, Dian-Yong Tang, et al.
Chemical Communications (Cambridge, England)
|
October 31, 2018
Catalyst free, C-3 functionalization of imidazo[1,2-a]pyridines to rapidly access new chemical space for drug discovery efforts
Naresh Gunaganti, Anupreet Kharbanda, Naga Rajiv Lakkaniga, et al.
Cancer Science
|
January 16, 2024
Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia
Brendan Frett, Kimberly E Stephens, Brian Koss, et al.
British Journal of Haematology
|
September 22, 2025
Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A-rearranged acute myeloid leukaemia
Arundhati Chavan, Brendan Frett, Daniel T Armstrong, et al.
Tetrahedron
|
August 28, 2012
Synthesis of Tetrazolo-Fused Benzodiazepines and Benzodiazepinones by a Two-Step Protocol Using an Ugi-Azide Reaction for Initial Diversity Generation
Steven Gunawan, Muhammad Ayaz, Fabio De Moliner, et al.
Genes
|
July 27, 2022
Targeting a Novel G-Quadruplex in the <i>CARD11</i> Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Kennith Swafford, Baku Acharya, Ying-Zhi Xu, et al.
European Journal of Medicinal Chemistry
|
August 22, 2020
Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation
Naga Rajiv Lakkaniga, Naresh Gunaganti, Lingtian Zhang, et al.
Journal of Medicinal Chemistry
|
August 17, 2021
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 24, 2025
Transforming growth factor β receptor 1 and mitogen-activated protein 4 kinase 4 dual inhibitor, TK-850, reduces renal fibrosis in unilateral ureteral-obstructed mice
Henry A Palfrey, Samaneh Goorani, Abhishek Mishra, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
European Journal of Medicinal Chemistry
|
March 14, 2015
Computer aided drug discovery of highly ligand efficient, low molecular weight imidazopyridine analogs as FLT3 inhibitors
Brendan Frett, Nick McConnell, Catherine C Smith, et al.
Molecular Diversity
|
January 18, 2018
Recent advances in the development of polycyclic skeletons via Ugi reaction cascades
Jie Lei, Jiang-Ping Meng, Dian-Yong Tang, et al.
Chemical Communications (Cambridge, England)
|
October 31, 2018
Catalyst free, C-3 functionalization of imidazo[1,2-a]pyridines to rapidly access new chemical space for drug discovery efforts
Naresh Gunaganti, Anupreet Kharbanda, Naga Rajiv Lakkaniga, et al.
Cancer Science
|
January 16, 2024
Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia
Brendan Frett, Kimberly E Stephens, Brian Koss, et al.
British Journal of Haematology
|
September 22, 2025
Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A-rearranged acute myeloid leukaemia
Arundhati Chavan, Brendan Frett, Daniel T Armstrong, et al.
Tetrahedron
|
August 28, 2012
Synthesis of Tetrazolo-Fused Benzodiazepines and Benzodiazepinones by a Two-Step Protocol Using an Ugi-Azide Reaction for Initial Diversity Generation
Steven Gunawan, Muhammad Ayaz, Fabio De Moliner, et al.
Genes
|
July 27, 2022
Targeting a Novel G-Quadruplex in the <i>CARD11</i> Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Kennith Swafford, Baku Acharya, Ying-Zhi Xu, et al.
European Journal of Medicinal Chemistry
|
August 22, 2020
Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation
Naga Rajiv Lakkaniga, Naresh Gunaganti, Lingtian Zhang, et al.
Journal of Medicinal Chemistry
|
August 17, 2021
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 24, 2025
Transforming growth factor β receptor 1 and mitogen-activated protein 4 kinase 4 dual inhibitor, TK-850, reduces renal fibrosis in unilateral ureteral-obstructed mice
Henry A Palfrey, Samaneh Goorani, Abhishek Mishra, et al.
Page
of 6